{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:45:31Z","timestamp":1790696731094,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/md.0000000000003736","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T15:07:09Z","timestamp":1464275229000},"page":"e3736","source":"Crossref","is-referenced-by-count":18,"title":["Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma"],"prefix":"10.1097","volume":"95","author":[{"given":"Yun Mi","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemi","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ji","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Yon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suck Joon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Bae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kee","family":"Shong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Lyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Eun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Gu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20210226","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ecl.2015.03.001","article-title":"Adrenocortical carcinoma","volume":"44","author":"Baudin","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R2-28-20210226","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"R3-28-20210226","doi-asserted-by":"crossref","first-page":"42","DOI":"10.12974\/2309-6160.2013.01.01.6","article-title":"Adrenocortical carcinoma: update of clinical features and diagnosis","volume":"1","author":"Gurzu","year":"2013","journal-title":"Global J Oncol"},{"key":"R4-28-20210226","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/PAT.0000000000000035","article-title":"Myxoid variant of adrenocortical carcinoma: a report of two illustrative cases and a brief review of the literature","volume":"46","author":"Gurzu","year":"2014","journal-title":"Pathology"},{"key":"R5-28-20210226","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assie","year":"2014","journal-title":"Nat Genet"},{"key":"R6-28-20210226","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.surg.2006.07.035","article-title":"Outcomes of adrenal cortical carcinoma in the United States","volume":"140","author":"Paton","year":"2006","journal-title":"Surgery"},{"key":"R7-28-20210226","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11934-007-0024-6","article-title":"Diagnosis and management of adrenal cortical carcinoma","volume":"8","author":"Fulmer","year":"2007","journal-title":"Curr Urol Rep"},{"key":"R8-28-20210226","doi-asserted-by":"crossref","first-page":"e1549","DOI":"10.1097\/MD.0000000000001549","article-title":"First case report of a sporadic adrenocortical carcinoma with gastric metastasis and a synchronous gastrointestinal stromal tumor of the stomach","volume":"94","author":"Kovecsi","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R9-28-20210226","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.hoc.2007.04.007","article-title":"Adrenal cortical carcinoma\u2014review of current knowledge and treatment practices","volume":"21","author":"Phan","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"R10-28-20210226","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2013-2856","article-title":"Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma","volume":"99","author":"Else","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-28-20210226","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ecl.2015.02.007","article-title":"Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis","volume":"44","author":"Nakamura","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R12-28-20210226","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/modpathol.2013.230","article-title":"Comparative diagnostic and prognostic performances of the hematoxylin\u2013eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma","volume":"27","author":"Duregon","year":"2014","journal-title":"Mod Pathol"},{"key":"R13-28-20210226","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1507\/endocrj.K07-079","article-title":"Immunohistochemistry of a proliferation marker Ki67\/MIB1 in adrenocortical carcinomas: Ki67\/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas","volume":"55","author":"Morimoto","year":"2008","journal-title":"Endocr J"},{"key":"R14-28-20210226","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-28-20210226","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ejca.2009.12.007","article-title":"The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation","volume":"46","author":"Lughezzani","year":"2010","journal-title":"Eur J Cancer"},{"key":"R16-28-20210226","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"R17-28-20210226","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-14-0273","article-title":"EJE prize 2014: current and evolving treatment options in adrenocortical carcinoma: where do we stand and where do we want to go?","volume":"171","author":"Ronchi","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"R18-28-20210226","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"N Engl J Med"},{"key":"R19-28-20210226","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/EJE-13-0519","article-title":"Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center","volume":"169","author":"Ayala-Ramirez","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"R20-28-20210226","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1245\/s10434-014-4133-4","article-title":"Improving outcomes in adrenocortical cancer: an Australian perspective","volume":"22","author":"Ip","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R21-28-20210226","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-28-20210226","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.surg.2007.09.006","article-title":"Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma","volume":"142","author":"Gonzalez","year":"2007","journal-title":"Surgery"},{"key":"R23-28-20210226","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-001-0047-y","article-title":"Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group","volume":"25","author":"Icard","year":"2001","journal-title":"World J Surg"},{"key":"R24-28-20210226","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma: clinical and laboratory observations","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"key":"R25-28-20210226","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/000313480507100118","article-title":"Adrenocortical carcinoma: a single institution experience","volume":"71","author":"Gomez-Rivera","year":"2005","journal-title":"Am Surg"},{"key":"R26-28-20210226","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000200804","article-title":"A twelve-year experience with adrenal cortical carcinoma in a single institution: long-term survival after surgical treatment and transcatheter arterial embolization","volume":"82","author":"Soga","year":"2009","journal-title":"Urol Int"},{"key":"R27-28-20210226","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3803\/EnM.2013.28.1.20","article-title":"Clinical characteristics for 348 patients with adrenal incidentaloma","volume":"28","author":"Kim","year":"2013","journal-title":"Endocrinol Metab (Seoul"},{"key":"R28-28-20210226","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.surg.2014.08.047","article-title":"Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease","volume":"156","author":"Livhits","year":"2014","journal-title":"Surgery"},{"key":"R29-28-20210226","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","article-title":"Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer","volume":"65","author":"Berruti","year":"2014","journal-title":"Eur Urol"},{"key":"R30-28-20210226","first-page":"1917","article-title":"Cortisol as a possible marker of metastatic adrenocortical carcinoma: a case report with 3-year follow-up","volume":"27","author":"Schwarte","year":"2007","journal-title":"Anticancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T16:54:27Z","timestamp":1692377667000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201605240-00028"}},"subtitle":["Usefulness of the Ki-67 Index"],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":30,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003736","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}